News

Healthcare

Staff Reporter

, APAC

Published:

2 years ago

218 views

Dustin Haines appointed as new leader of Gilead Sciences' "Asia 5." /Gilead Sciences photo

Gilead Sciences names its new health leader for Asia markets

Dustin Haines has 20 years leadership in pharmaceuticals.

To improve public health and community in five Asian markets, Gilead Sciences, a biopharmaceutical firm, appointed pharmaceutical veteran Dustin Haines as its general manager and vice president for Asia 5 starting 6 June 2022.

Haines, who served corporate leadership in pharmaceuticals for 20 years, will be at the helm of driving the business development of HIV and viral hepatitis including hepatitis B, C, and D, as well as Gilead’s commitment to boosting public health and community impact in Hong Kong, Singapore, South Korea, Taiwan, and Malaysia.

Prior to his appointment, Haines served as the chief commercial officer of Next Science, a medical technology firm.

For over 10 years, he worked with ViiV Healthcare and GSK, last serving as president and general manager for Japan at ViiV Healthcare.

Follow the link for more news on

Gilead Sciences

Dustin Haines

Also Read

Dental radiology equipment market to grow by $2.45b by 2028

What to expect with Australia’s $739m Frankston Hospital Redevelopment?

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit